Literature DB >> 26871486

Stimuli-Responsive Codelivery of Oligonucleotides and Drugs by Self-Assembled Peptide Nanoparticles.

Severin J Sigg1, Viktoriia Postupalenko1, Jason T Duskey1, Cornelia G Palivan1, Wolfgang Meier1.   

Abstract

Ever more emerging combined treatments exploiting synergistic effects of drug combinations demand smart, responsive codelivery carriers to reveal their full potential. In this study, a multifunctional stimuli-responsive amphiphilic peptide was designed and synthesized to self-assemble into nanoparticles capable of co-bearing and -releasing hydrophobic drugs and antisense oligonucleotides for combined therapies. The rational design was based on a hydrophobic l-tryptophan-d-leucine repeating unit derived from a truncated sequence of gramicidin A (gT), to entrap hydrophobic cargo, which is combined with a hydrophilic moiety of histidines to provide electrostatic affinity to nucleotides. Stimuli-responsiveness was implemented by linking the hydrophobic and hydrophilic sequence through an artificial amino acid bearing a disulfide functional group (H3SSgT). Stimuli-responsive peptides self-assembled in spherical nanoparticles in sizes (100-200 nm) generally considered as preferable for drug delivery applications. Responsive peptide nanoparticles revealed notable nucleotide condensing abilities while maintaining the ability to load hydrophobic cargo. The disulfide cleavage site introduced in the peptide sequence induced responsiveness to physiological concentrations of reducing agent, serving to release the incorporated molecules. Furthermore, the peptide nanoparticles, singly loaded or coloaded with boron-dipyrromethene (BODIPY) and/or antisense oligonucleotides, were efficiently taken up by cells. Such amphiphilic peptides that led to noncytotoxic, reduction-responsive nanoparticles capable of codelivering hydrophobic and nucleic acid payloads simultaneously provide potential toward combined treatment strategies to exploit synergistic effects.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26871486     DOI: 10.1021/acs.biomac.5b01614

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  4 in total

1.  Orthogonally Stimulated Assembly/Disassembly of Depsipeptides by Rational Chemical Design.

Authors:  Michaela Pieszka; Adriana Maria Sobota; Jasmina Gačanin; Tanja Weil; David Y W Ng
Journal:  Chembiochem       Date:  2019-04-12       Impact factor: 3.164

Review 2.  Smart Nanoparticles for Chemo-Based Combinational Therapy.

Authors:  Binita Shrestha; Lijun Wang; Eric M Brey; Gabriela Romero Uribe; Liang Tang
Journal:  Pharmaceutics       Date:  2021-06-08       Impact factor: 6.525

3.  Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy.

Authors:  Masoud Delfi; Rossella Sartorius; Milad Ashrafizadeh; Esmaeel Sharifi; Yapei Zhang; Piergiuseppe De Berardinis; Ali Zarrabi; Rajender S Varma; Franklin R Tay; Bryan Ronain Smith; Pooyan Makvandi
Journal:  Nano Today       Date:  2021-03-11       Impact factor: 18.962

Review 4.  Peptide-Based Nanoassemblies in Gene Therapy and Diagnosis: Paving the Way for Clinical Application.

Authors:  Shabnam Tarvirdipour; Xinan Huang; Voichita Mihali; Cora-Ann Schoenenberger; Cornelia G Palivan
Journal:  Molecules       Date:  2020-07-31       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.